Advertisement
Screener

TVARDI THERAPEUTICS, INC. (TVRD) Capital Expenditures

2.8 / 5 stars · 68/120 Roast Me

TVARDI THERAPEUTICS, INC. Capital Expenditures

TVARDI THERAPEUTICS, INC. (TVRD) reported Capital Expenditures of $1.05 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-11.

Financial Statements › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2025-05-13

  • TVARDI THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
  • TVARDI THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2024-09-30 was $0.00.
  • TVARDI THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2024-06-30 was $210.00K.
  • TVARDI THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2024-03-31 was $836.00K.
  • TVARDI THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $1.05M, a 55.96% decline from fiscal 2023.
  • TVARDI THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $2.38M, a 5423.26% increase from fiscal 2022.
  • TVARDI THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $43.00K, a 10.26% increase from fiscal 2021.
  • TVARDI THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2021 was $39.00K, a 88.83% decline from fiscal 2020.
Period endPayments to Acquire Property, Plant, and Equipment 3 monthPayments to Acquire Property, Plant, and Equipment 6 monthPayments to Acquire Property, Plant, and Equipment 9 monthPayments to Acquire Property, Plant, and Equipment 12 month
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11
$0.00
derived: sum of 2 quarters · filed 2025-03-11
$210.00K
derived: sum of 3 quarters · filed 2025-03-11
$1.05M
10-K · filed 2025-03-11
2024-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
$210.00K
derived: sum of 2 quarters · filed 2024-11-14
$1.05M
10-Q · filed 2024-11-14
$3.10M
derived: sum of 4 quarters · filed 2025-05-13
2024-06-30$210.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14
$1.05M
10-Q · filed 2024-08-14
$3.10M
derived: sum of 3 quarters · filed 2025-05-13
2024-03-31$836.00K
10-Q · filed 2025-05-13
$2.89M
derived: sum of 2 quarters · filed 2025-05-13
2023-12-31$2.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11
$2.38M
10-K · filed 2025-03-11
2023-09-30$323.00K
10-Q · filed 2024-11-14
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11
$0.00
derived: sum of 2 quarters · filed 2025-03-11
$0.00
derived: sum of 3 quarters · filed 2025-03-11
$43.00K
10-K · filed 2025-03-11
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13
$0.00
derived: sum of 2 quarters · filed 2023-11-13
$43.00K
10-Q · filed 2023-11-13
2022-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07
$43.00K
10-Q · filed 2023-08-07
2022-03-31$43.00K
10-Q · filed 2023-05-15
2021-12-31$39.00K
10-K · filed 2024-03-06
2020-12-31$167.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06
$349.00K
10-K · filed 2023-03-06
2020-09-30$182.00K
10-Q · filed 2021-11-08
2019-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$0.00
derived: sum of 2 quarters · filed 2022-03-01
$7.00K
derived: sum of 3 quarters · filed 2022-03-01
$18.00K
10-K · filed 2022-03-01
2019-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
$7.00K
derived: sum of 2 quarters · filed 2020-11-09
$18.00K
10-Q · filed 2020-11-09
$42.00K
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30$7.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
$18.00K
10-Q · filed 2020-08-10
$42.00K
derived: sum of 3 quarters · filed 2021-02-25
$70.00K
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31$11.00K
10-Q · filed 2020-05-11
$35.00K
derived: sum of 2 quarters · filed 2021-02-25
$63.00K
derived: sum of 3 quarters · filed 2021-02-25
$82.00K
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31$24.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
$52.00K
derived: sum of 2 quarters · filed 2021-02-25
$71.00K
derived: sum of 3 quarters · filed 2021-02-25
$73.00K
10-K · filed 2021-02-25
2018-09-30$28.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05
$47.00K
derived: sum of 2 quarters · filed 2019-11-05
$49.00K
10-Q · filed 2019-11-05
$49.00K
derived: sum of 4 quarters · filed 2020-02-27
2018-06-30$19.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
$21.00K
10-Q · filed 2019-08-07
$21.00K
derived: sum of 3 quarters · filed 2020-02-27
$49.00K
derived: sum of 4 quarters · filed 2020-02-27
2018-03-31$2.00K
10-Q · filed 2019-05-07
$2.00K
derived: sum of 2 quarters · filed 2020-02-27
$30.00K
derived: sum of 3 quarters · filed 2020-02-27
$52.00K
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$28.00K
derived: sum of 2 quarters · filed 2020-02-27
$50.00K
derived: sum of 3 quarters · filed 2020-02-27
$58.00K
10-K · filed 2020-02-27
2017-09-30$28.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
$50.00K
derived: sum of 2 quarters · filed 2018-11-06
$58.00K
10-Q · filed 2018-11-06
$127.00K
derived: sum of 4 quarters · filed 2019-03-12
2017-06-30$22.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07
$30.00K
10-Q · filed 2018-08-07
$99.00K
derived: sum of 3 quarters · filed 2019-03-12
$589.00K
derived: sum of 4 quarters · filed 2019-03-12
2017-03-31$8.00K
10-Q · filed 2018-05-09
$77.00K
derived: sum of 2 quarters · filed 2019-03-12
$567.00K
derived: sum of 3 quarters · filed 2019-03-12
$717.00K
derived: sum of 4 quarters · filed 2019-03-12
2016-12-31$69.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12
$559.00K
derived: sum of 2 quarters · filed 2019-03-12
$709.00K
derived: sum of 3 quarters · filed 2019-03-12
$717.00K
10-K · filed 2019-03-12
2016-09-30$490.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02
$640.00K
derived: sum of 2 quarters · filed 2017-11-02
$648.00K
10-Q · filed 2017-11-02
$655.00K
derived: sum of 4 quarters · filed 2018-03-15
2016-06-30$150.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03
$158.00K
10-Q · filed 2017-08-03
$165.00K
derived: sum of 3 quarters · filed 2018-03-15
$166.00K
derived: sum of 4 quarters · filed 2018-03-15
2016-03-31$8.00K
10-Q · filed 2017-05-04
$15.00K
derived: sum of 2 quarters · filed 2018-03-15
$16.00K
derived: sum of 3 quarters · filed 2018-03-15
$22.00K
derived: sum of 4 quarters · filed 2018-03-15
2015-12-31$7.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15
$8.00K
derived: sum of 2 quarters · filed 2018-03-15
$14.00K
derived: sum of 3 quarters · filed 2018-03-15
$20.00K
10-K · filed 2018-03-15
2015-09-30$1.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04
$7.00K
derived: sum of 2 quarters · filed 2016-11-04
$13.00K
10-Q · filed 2016-11-04
$28.00K
derived: sum of 4 quarters · filed 2017-03-10
2015-06-30$6.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
$12.00K
10-Q · filed 2016-08-04
$27.00K
derived: sum of 3 quarters · filed 2017-03-10
$48.00K
derived: sum of 4 quarters · filed 2017-03-10
2015-03-31$6.00K
10-Q · filed 2016-05-05
$21.00K
derived: sum of 2 quarters · filed 2017-03-10
$42.00K
derived: sum of 3 quarters · filed 2017-03-10
2014-12-31$15.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10
$36.00K
derived: sum of 2 quarters · filed 2017-03-10
$42.00K
10-K · filed 2017-03-10
2014-09-30$21.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09
$27.00K
10-Q · filed 2015-11-09
2014-06-30$6.00K
10-Q · filed 2015-08-10
2013-12-31$1.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11
$5.00K
10-K · filed 2016-03-11
2013-09-30$4.00K
10-Q · filed 2014-11-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
MUSTANG BIO, INC. (MBIO)United States$0.013B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36